Back to search

University of Patras

Ανάπτυξη in vitro συστημάτων καλλιεργειών δενδριτικών κυττάρων για την αντιγονοπαρουσίαση τεχνητών αντιγόνων σε Τ κύτταρα ασθενών με σκλήρυνση κατά πλάκας με απώτερο σκοπό τη δημιουργία θεραπευτικών εμβολίων

Abstract

dc:description

Multiple sclerosis (MS) is an autoimmune disease which affects the central nervous system and its pathogenetic mechanism is orchestrated mostly by autoreactive T and B cells which escaped the mechanisms of immunological tolerance. The induction of immunological tolerance through the action of dendritic cells is a new-introduced strategy for the treatment of MS. The aim of this dissertation is the generation and the study of antigen presentation of the mannan congugated peptide MOG35-55 by tolerogenic dendritic cells (tolDCs), which present the peptide to T cells in order to induce tolerance. In our experimental protocol, peripheral blood mononuclear cells (PBMCs) were isolated from healthy individuals and patients with RR-MS. PBMCs were differentiated in several types of DCs in the presence of IL-4 and GM-CSF, with or without the addition of dexamethasone(DEXA), vitamin D3(VitD3) or the combination DEXA+VitD3. On day 6 of culture, DCs were loaded with the peptide or mannan only and received the LPS maturation signal. On day 8, DCs were co-cultured with autologous PBMCs in the presence of IL-2 for 3 or 4 antigen-presentation circles. The phenotypes of DCs and T cell populations were analyzed using flow cytometry. The cytokine secretion profiles of DCs and T cells were determined with Cytometric Bead Arrays for the following cytokines: IL-1β/IL-2/IL-4/IL-6/IL-8/IL-10/IL-12p70/IL-17A/TNF-α/IFN-γ and ELISA for TGF-β1.The study and analysis of DCs on day 8 revealed that tolDCs had the lower surface expression of CD80 and CD86 molecules and higher IL-10 compared to mature DCs, and this allowed the phenotypic and functional separation between mature and tolerogenic DCs. The co-cultures of PBMCs with the different types of DCs, after 3 or 4 antigen presentation circles, promoted the generation of memory of CD4 but not of CD8 T cells. From the estimation of activation levels of CD4 T cells, we observed an inhibition of activation in the co-cultures with tolDCs which presented the peptide. These results were followed by a simultaneous increase in the percentages of exhausted CD4+PD-1+ and regulatory CD4+CD25highFoxP3+ Τ cells and the secretion of IL-10 or/and TGF-β1. These results suggest that the peptide loaded tolDCs, which we generated in vitro, induce tolerance on T cells and can be used as a therapeutic vaccine for MS.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Rodi, Maria
  • Ρόδη, Μαρία

Subjects

dc:subject × 16

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/44467

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Rodi, Maria; Ρόδη, Μαρία. Ανάπτυξη in vitro συστημάτων καλλιεργειών δενδριτικών κυττάρων για την αντιγονοπαρουσίαση τεχνητών αντιγόνων σε Τ κύτταρα ασθενών με σκλήρυνση κατά πλάκας με απώτερο σκοπό τη δημιουργία θεραπευτικών εμβολίων. University of Patras, 2018. http://hdl.handle.net/10442/hedi/44467